Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
You may also be interested in...
Spark's Gene Therapy Luxturna Sails Through US FDA Panel
Improvements seen in multi-luminance mobility testing in the voretigene Phase III trial were clinically meaningful, panelists said, endorsing the novel endpoint for the vision loss treatment. They also were persuaded by first-hand accounts from patients.
Aerie's Netarsudil's Safety Questions May Determine Fate At Advisory Committee
Proposed treatment for elevated intraocular pressure would be first in new rho-associated protein kinase inhibitor class.
FDA's Advisory Cmte. Meeting On Bladder Pain Syndrome May Signal Policy Changes
The Bone, Reproductive and Urologic Drugs Advisory Committee will consider endpoints, clinical trial designs and other issues related to development in the disease.